Tyra Biosciences, Inc. TYRA Return on equity

Return on equity at other companies

IncyteINCY

30.7%+6.4pp

BioMarin PharmaceuticalsBMRN

9.1%+2.8pp

ArriVent BioPharma, Inc.AVBP

-55.2%+8.0pp

Syndax PharmaceuticalsSNDX

-189.5%-8,509pp

Kura OncologyKURA

-124.7%-252pp

Bicara TherapeuticsBCAX

-32.3%—

FAQ

What is Tyra Biosciences, Inc.'s return on equity?

Tyra Biosciences, Inc. (TYRA) reported return on equity of -36.9% in Q1 2026.

How has Tyra Biosciences, Inc.'s return on equity changed year-over-year?

Tyra Biosciences, Inc.'s return on equity decreased by 36.4% year-over-year, from -27% to -36.9%.

What is the long-term trend for Tyra Biosciences, Inc.'s return on equity?

Over 3 years (2022 to 2025), Tyra Biosciences, Inc.'s return on equity has grown at a 26.3% compound annual growth rate (CAGR), from -19.8% to -39.8%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.